Omalizumab, the only FDA-approved treatment for multiple food allergies, demonstrated significant efficacy in the OUtMATCH trial, with 67% achieving the primary outcome compared to 7% in the placebo group.
Why Second Dose of COVID-19 Vaccine Should Not Be Skipped, Shows Study latestly.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from latestly.com Daily Mail and Mail on Sunday newspapers.
Study shows why second dose of COVID-19 vaccine should not be skipped ANI | Updated: Jul 20, 2021 08:21 IST
Washington [US], July 20 (ANI): The second dose of a COVID-19vaccine induces a powerful boost to a part of the immune system that provides broad antiviral protection, according to a study led by investigators at the Stanford University School of Medicine.
The findings published in the journal Nature strongly supports the view that the second shot should not be skipped. Despite their outstanding efficacy, little is known about how exactly RNA vaccines work, said Bali Pulendran, PhD, professor of pathology and of microbiology and immunology. So we probed the immune response induced by one of them in exquisite detail.
Study: Second dose of COVID-19 vaccine induces a powerful boost to the immune system
The second dose of a COVID-19 vaccine induces a powerful boost to a part of the immune system that provides broad antiviral protection, according to a study led by investigators at the Stanford University School of Medicine.
The finding strongly supports the view that the second shot should not be skipped.
Despite their outstanding efficacy, little is known about how exactly RNA vaccines work. So we probed the immune response induced by one of them in exquisite detail.
Bali Pulendran, PhD, professor of pathology and of microbiology and immunology
Here s why you should not skip the second dose of COVID-19 vaccine deccanchronicle.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from deccanchronicle.com Daily Mail and Mail on Sunday newspapers.